Skip to main content

X-NOVATION TALKS - Episode #6

Online meeting

Get connected!

Your meeting | X-Novation Talks |

Thursday, June 03 - 12:30 to 13:45 - Online

Biotech and Innovations : An ever more personalized medicine

 

X-Novation Talks gives voice to the actors of innovation and allows its audience to exchange on various topics at the forefront of technology and scientific research.

 

Each patient has his or her own individual characteristics and requires specifically adapted, effective, tolerable and sustainable care. This is what personalized medicine is all about, with intervention at all the major stages of the care process: prevention, diagnosis, treatment and follow-up.

It is in this perspective that biotechnologies applied to the medical sector take on their full meaning. They represent one of the most promising growth markets for the coming years. They link the scientific community and the economic world.

The idea of personalized medicine was born at the end of the 1990s. Advances in the sequencing of the human genome offered its first promises in the medical field, particularly for predicting certain diseases, such as cancer. The interest for these new practices is more than ever relevant because of the field of possibilities opened by the massive collection of data.

The data at the origin of the development of personalized medicine constitute the health big data. Its sources are many and varied: clinical trials, computerized records, web and health applications, connected objects, etc.

Increasingly numerous and precise, the information collected helps to enrich databases and to improve artificial intelligence software that supports healthcare professionals in order to monitor the progression of a chronic disease, or to detect pathology determinants, risk factors, or the links between a pathology and a behavior, for example, a dietary behavior.

The biotech sector is traditionally represented by young companies with advanced scientific expertise, investing in R&D and marketing goods or services.

Four French companies specializing in this field, with complementary profiles, will come and talk to you about their commitment and activities in this field:

* Hillo, the first mobile, predictive, personalized service for monitoring and predicting blood glucose variations.

* Ummon HealthTech, a proprietary AI-powered platform that helps pathologists identify cancer cells more accurately, earlier and faster.

* Inria / Ecole polytechnique (CMAP), The National Institute for Research in Digital Science and Technology and the Center for Applied Mathematics (CMAP) at the École Polytechnique - "When Mathematics Treats Medicine".

* Medicen, a global competitiveness cluster for innovative technologies for health and new therapies.

 

Our guests :

Nicolas CALECA | Hillo | Co-founder & CEO

Louis-Oscar MOREL | Ummon HealthTech | Co-founder & CEO

Marc LAVIELLE | INRIA / Ecole Polytechnique | Director of research in statistics at Inria and professor at the Center for Applied Mathematics (CMAP) at the École Polytechnique (IP Paris)

Julie BAUSSAND | Medicen | Health Innovation Project Manager

 

Sign up here to receive the Zoom login link on the day of the webinar.

 

If you wish to receive all our news at X-Entrepreneurship, subscribe to our Newsletter here